The analysis of TIMP-1 mRNA expression in breast cancer specimens revealed that TIMP-1 is expressed more highly in TNBC than in normal breast tissue, and the higher serum TIMP-1 levels in the malignant tissue are associated with a poor prognosis. This evidence concerns the gene TIMP1 and breast cancer.